2020
DOI: 10.1038/s41698-020-0122-1
|View full text |Cite
|
Sign up to set email alerts
|

Machine learning approaches to drug response prediction: challenges and recent progress

Abstract: Cancer is a leading cause of death worldwide. Identifying the best treatment using computational models to personalize drug response prediction holds great promise to improve patient’s chances of successful recovery. Unfortunately, the computational task of predicting drug response is very challenging, partially due to the limitations of the available data and partially due to algorithmic shortcomings. The recent advances in deep learning may open a new chapter in the search for computational drug response pre… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
150
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 219 publications
(153 citation statements)
references
References 108 publications
1
150
0
Order By: Relevance
“…However, mechanisms can still be tested using gene manipulation techniques such as CRISPR, non-coding RNAs, and/or gene overexpression to prove the concepts, encouraging researchers and pharmaceutical companies to design therapeutics for these candidate targets. Rapid growing in the field of computational drug discovery, artificial intelligence, and big pharmacogenomic/proteomic databases and tools [107][108][109][110][111][112][113][114][115] to predict molecular targets, mechanisms of action, drug responses and adverse effects will eventually benefit the pipeline of the master regulator-targeted immunotherapeutic strategies, even though rounds of extensive benchmarking and testing in vitro and in vivo are needed before full potentials of in silico approaches can be unleashed in clinical settings. Implementation of the user-friendly, web-based programs brings a huge opportunity to scientists and clinicians knowledgeable in biology and disease-specific contexts but have less-to-no coding skills.…”
Section: Prospects On Therapeutic Targeting Master Regulators Of Icsmentioning
confidence: 99%
“…However, mechanisms can still be tested using gene manipulation techniques such as CRISPR, non-coding RNAs, and/or gene overexpression to prove the concepts, encouraging researchers and pharmaceutical companies to design therapeutics for these candidate targets. Rapid growing in the field of computational drug discovery, artificial intelligence, and big pharmacogenomic/proteomic databases and tools [107][108][109][110][111][112][113][114][115] to predict molecular targets, mechanisms of action, drug responses and adverse effects will eventually benefit the pipeline of the master regulator-targeted immunotherapeutic strategies, even though rounds of extensive benchmarking and testing in vitro and in vivo are needed before full potentials of in silico approaches can be unleashed in clinical settings. Implementation of the user-friendly, web-based programs brings a huge opportunity to scientists and clinicians knowledgeable in biology and disease-specific contexts but have less-to-no coding skills.…”
Section: Prospects On Therapeutic Targeting Master Regulators Of Icsmentioning
confidence: 99%
“…The improvement is most prominent when using drug targets to help the prediction of drug response. Drug target is known to be one of the most important features in a variety of drug response prediction approaches [42][43][44] , partly due to its central role in understanding drug mechanisms. Interestingly, drug response is much less helpful for drug target prediction.…”
Section: Drugorchestra Reveals Transferability Across Tasksmentioning
confidence: 99%
“…Advances in statistical and machine learning approaches enable (mostly) data-driven exploration and hypothesis generation from big datasets (5)(6)(7)(8). Trained on features of the input dataset(s), such models can be used for, as just a few examples, to predict drug responses (9)(10)(11) or decide tumor type/stage (12)(13)(14)(15). Although transformative, such machine learning and statistical models have shortcomings.…”
Section: Introductionmentioning
confidence: 99%